Berberine attenuates hyperalgesia in mice with adenomyosis

Lab / animal OA: closed public-domain-us
Full text JSON View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-07 ⓘ

Berberine reduced hyperalgesia and adenomyosis symptoms in mice by downregulating pain and inflammation-related genes and inflammatory responses.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text ⓘ

The study investigated the analgesic and disease-curative effects of berberine in a tamoxifen-induced neonatal mouse model of adenomyosis, using hotplate and tail-flick tests to assess pain and RT-qPCR, ELISA, and Western blot to measure gene and protein expression. Berberine was administered intraperitoneally at 5, 10, and 20 mg/kg starting at 17 weeks after birth, and it reduced uterine weight, suppressed myometrial infiltration by ectopic endometrium, and improved hyperalgesia-related behavioral measures. Mechanistically, berberine downregulated pain and inflammation-associated markers (including TRPV1, COX-2, VEGF, and OTR), reduced inflammatory responses in the DRG, and inhibited TLR4 expression in DRG and uterine tissues. The paper does not provide detailed human relevance limits or specify whether effects generalize beyond this model, aside from using the stated mouse system. This paper is centrally about adenomyosis — it tests whether berberine attenuates hyperalgesia and reduces adenomyosis pathology in tamoxifen-induced neonatal mice.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

PURPOSE: Adenomyosis is a common gynecological disease, but its pathogenesis and treatment options are not yet completely clear. This study aimed to investigate the analgesic effect of berberine on tamoxifen-induced neonatal mouse adenomyosis and its curative effects on the disease. METHODS: The mouse adenomyosis model was established in neonatal female mice via oral administration of tamoxifen suspended solution. Adenomyosis mice were given berberine by intraperitoneal injection with the dosage of 5, 10, and 20 mg/kg body weight, respectively, at 17 weeks after birth. The pain sensation of the mice was evaluated by hotplate and tail-flick tests. The mRNA levels of gene expression were detected by RT-qPCR. The protein expression was analyzed by ELISA and Western blot. RESULTS: Berberine reduced the uterine weight, suppressed the myometrial infiltration of ectopic endometrium, improved the hotplate and tail-flick latency of the adenomyosis mice. Mechanistically, berberine downregulated the expression of genes related to pain and inflammation, such as TRPV1, COX-2, VEGF and OTR, impaired the inflammatory response at the DRG site, and inhibited the expression of TLR4 in DRG and uterine tissues. CONCLUSIONS: Berberine attenuates hyperalgesia and exhibits analgesic and therapeutic effects on adenomyosis mice.
Full text 9,390 characters · extracted from oa-doi-fallback · 5 sections · click to expand

Abstract

Purpose Adenomyosis is a common gynecological disease, but its pathogenesis and treatment options are not yet completely clear. This study aimed to investigate the analgesic effect of berberine on tamoxifen-induced neonatal mouse adenomyosis and its curative effects on the disease.

Methods

The mouse adenomyosis model was established in neonatal female mice via oral administration of tamoxifen suspended solution. Adenomyosis mice were given berberine by intraperitoneal injection with the dosage of 5, 10, and 20 mg/kg body weight, respectively, at 17 weeks after birth. The pain sensation of the mice was evaluated by hotplate and tail-flick tests. The mRNA levels of gene expression were detected by RT-qPCR. The protein expression was analyzed by ELISA and Western blot.

Results

Berberine reduced the uterine weight, suppressed the myometrial infiltration of ectopic endometrium, improved the hotplate and tail-flick latency of the adenomyosis mice. Mechanistically, berberine downregulated the expression of genes related to pain and inflammation, such as TRPV1, COX-2, VEGF and OTR, impaired the inflammatory response at the DRG site, and inhibited the expression of TLR4 in DRG and uterine tissues.

Conclusions

Berberine attenuates hyperalgesia and exhibits analgesic and therapeutic effects on adenomyosis mice. Similar content being viewed by others Data availability The data supporting the results of this article are included within the article. Further enquiries can be directed to the corresponding author. Code availability Not applicable.

References

Guo J, Chen L, Luo N, Li C, Chen R, Qu X, Liu M, Kang L, Cheng Z (2016) LPS/TLR4-mediated stromal cells acquire an invasive phenotype and are implicated in the pathogenesis of adenomyosis. Sci Rep 6:21416. https://doi.org/10.1038/srep21416 Di Donato N, Seracchioli R (2014) How to evaluate adenomyosis in patients affected by endometriosis? Minim Invasive Surg 2014:507230. https://doi.org/10.1155/2014/507230 Korzekwa A, Lupicka M, Socha B, Mannelli C, Skarzynski DJ (2014) Is adenomyosis a problem in reproduction and fertility? Pol J Vet Sci 17:187–194. https://doi.org/10.2478/pjvs-2014-0028 Exacoustos C, Manganaro L, Zupi E (2014) Imaging for the evaluation of endometriosis and adenomyosis. Best Pract Res Clin Obstet Gynaecol 28:655–681. https://doi.org/10.1016/j.bpobgyn.2014.04.010 Zhang Y, Zhou L, Li TC, Duan H, Yu P, Wang HY (2014) Ultrastructural features of endometrial-myometrial interface and its alteration in adenomyosis. Int J Clin Exp Pathol 7:1469–1477 Garcia L, Isaacson K (2011) Adenomyosis: review of the literature. J Minim Invasive Gynecol 18:428–437. https://doi.org/10.1016/j.jmig.2011.04.004 Yuan H, Zhang S (2019) Malignant transformation of adenomyosis: literature review and meta-analysis. Arch Gynecol Obstet 299:47–53. https://doi.org/10.1007/s00404-018-4991-2 Taran FA, Stewart EA, Brucker S (2013) Adenomyosis: epidemiology, risk factors, clinical phenotype and surgical and interventional alternatives to hysterectomy. Geburtshilfe Frauenheilkd 73:924–931. https://doi.org/10.1055/s-0033-1350840 Sun Y, Xun K, Wang Y, Chen X (2009) A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anticancer Drugs 20:757–769. https://doi.org/10.1097/CAD.0b013e328330d95b He W, Wang B, Zhuang Y, Shao D, Sun K, Chen J (2012) Berberine inhibits growth and induces G1 arrest and apoptosis in human cholangiocarcinoma QBC939 cells. J Pharmacol Sci 119:341–348. https://doi.org/10.1254/jphs.12052fp Liu Q, Xu X, Zhao M, Wei Z, Li X, Zhang X, Liu Z, Gong Y, Shao C (2015) Berberine induces senescence of human glioblastoma cells by downregulating the EGFR-MEK-ERK signaling pathway. Mol Cancer Ther 14:355–363. https://doi.org/10.1158/1535-7163.MCT-14-0634 Dong J, Zuo Z, Yan W, Liu W, Zheng Q, Liu X (2019) Berberine ameliorates diabetic neuropathic pain in a rat model: involvement of oxidative stress, inflammation, and mu-opioid receptors. Naunyn Schmiedebergs Arch Pharmacol 392:1141–1149. https://doi.org/10.1007/s00210-019-01659-6 Yang S, Yu Z, Sun W, Jiang C, Ba X, Zhou Q, Xiong D, Xiao L, Deng Q, Hao Y (2020) The antiviral alkaloid berberine ameliorates neuropathic pain in rats with peripheral nerve injury. Acta Neurol Belg 120:557–564. https://doi.org/10.1007/s13760-018-1006-9 Liu L, Luo N, Guo J, Xie Y, Chen L, Cheng Z (2018) Berberine inhibits growth and inflammatory invasive phenotypes of ectopic stromal cells: imply the possible treatment of adenomyosis. J Pharmacol Sci 137:5–11. https://doi.org/10.1016/j.jphs.2017.12.001 Liu X, Guo SW (2011) Valproic acid alleviates generalized hyperalgesia in mice with induced adenomyosis. J Obstet Gynaecol Res 37:696–708. https://doi.org/10.1111/j.1447-0756.2011.01655.x Nie J, Liu X (2017) Quercetin alleviates generalized hyperalgesia in mice with induced adenomyosis. Mol Med Rep 16:5370–5376. https://doi.org/10.3892/mmr.2017.7238 Ye J, Cai X, Wang D, Zhang F, Wang Z, Cao M, Pang Z, Yang J, Yan H, Li J, Cao P, Hu C (2020) Shi Xiao San ameliorates the development of adenomyosis in an ICR mouse model. Exp Ther Med 20:2845–2855. https://doi.org/10.3892/etm.2020.8994 Zhu B, Chen Y, Zhang H, Liu X, Guo SW (2015) Resveratrol reduces myometrial infiltration, uterine hyperactivity, and stress levels and alleviates generalized hyperalgesia in mice with induced adenomyosis. Reprod Sci 22:1336–1349. https://doi.org/10.1177/1933719115572479 Bergeron C, Amant F, Ferenczy A (2006) Pathology and physiopathology of adenomyosis. Best Pract Res Clin Obstet Gynaecol 20:511–521. https://doi.org/10.1016/j.bpobgyn.2006.01.016 Tsui KH, Lee WL, Chen CY, Sheu BC, Yen MS, Chang TC, Wang PH (2014) Medical treatment for adenomyosis and/or adenomyoma. Taiwan J Obstet Gynecol 53:459–465. https://doi.org/10.1016/j.tjog.2014.04.024 Ueda M, Yamashita Y, Takehara M, Terai Y, Kumagai K, Ueki K, Kanda K, Yamaguchi H, Akise D, Hung YC, Ueki M (2002) Survivin gene expression in endometriosis. J Clin Endocrinol Metab 87:3452–3459. https://doi.org/10.1210/jcem.87.7.8682 Nezhat F, Cohen C, Rahaman J, Gretz H, Cole P, Kalir T (2002) Comparative immunohistochemical studies of bcl-2 and p53 proteins in benign and malignant ovarian endometriotic cysts. Cancer 94:2935–2940. https://doi.org/10.1002/cncr.10566 Yang JH, Wu MY, Chen CD, Chen MJ, Yang YS, Ho HN (2007) Altered apoptosis and proliferation in endometrial stromal cells of women with adenomyosis. Hum Reprod 22:945–952. https://doi.org/10.1093/humrep/del493 Schwartz ES, La JH, Scheff NN, Davis BM, Albers KM, Gebhart GF (2013) TRPV1 and TRPA1 antagonists prevent the transition of acute to chronic inflammation and pain in chronic pancreatitis. J Neurosci 33:5603–5611. https://doi.org/10.1523/JNEUROSCI.1806-12.2013 Han AM, Heo H, Kwon YK (2012) Berberine promotes axonal regeneration in injured nerves of the peripheral nervous system. J Med Food 15:413–417. https://doi.org/10.1089/jmf.2011.2029 Rezaee R, Monemi A, SadeghiBonjar MA, Hashemzaei M (2019) Berberine alleviates paclitaxel-induced neuropathy. J Pharmacopuncture 22:90–94. https://doi.org/10.3831/KPI.2019.22.011 Ni W, Zheng X, Hu L, Kong C, Xu Q (2021) Preventing oxaliplatin-induced neuropathic pain: Using berberine to inhibit the activation of NF-kappaB and release of pro-inflammatory cytokines in dorsal root ganglions in rats. Exp Ther Med 21:135. https://doi.org/10.3892/etm.2020.9567 He Q, Mei D, Sha S, Fan S, Wang L, Dong M (2017) ERK-dependent mTOR pathway is involved in berberine-induced autophagy in hepatic steatosis. J Mol Endocrinol 59:X1. https://doi.org/10.1530/JME-16-0139e Kong WJ, Zhang H, Song DQ, Xue R, Zhao W, Wei J, Wang YM, Shan N, Zhou ZX, Yang P, You XF, Li ZR, Si SY, Zhao LX, Pan HN, Jiang JD (2009) Berberine reduces insulin resistance through protein kinase C-dependent up-regulation of insulin receptor expression. Metabolism 58:109–119. https://doi.org/10.1016/j.metabol.2008.08.013 Croce CM, Reed JC (2016) Finally, an apoptosis-targeting therapeutic for cancer. Cancer Res 76:5914–5920. https://doi.org/10.1158/0008-5472.CAN-16-1248 Funding This study was funded by the Basic Public Research Project of Zhejiang Province (LGF19H040014). Author information Authors and Affiliations Contributions XS project development, data collection, manuscript editing; HZ project development, data management, manuscript editing; YC, MG, CZ, LH, QP, TL, YL data collection and analysis; BZ manuscript writing and review, data analysis. Corresponding authors Ethics declarations Conflict of interest The authors declare that they have no known conflicts of interest. Ethical approval Animal research was approved by the institutional animal care and use committee of Wenzhou People’s Hospital. Consent to participate Not applicable. Consent for publication All authors reviewed the results and approved the final version of the manuscript. Additional information Publisher's Note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Rights and permissions About this article Cite this article Zhu, B., Chen, Y., Guo, M. et al. Berberine attenuates hyperalgesia in mice with adenomyosis. Arch Gynecol Obstet 306, 115–125 (2022). https://doi.org/10.1007/s00404-022-06438-y Received: Accepted: Published: Version of record: Issue date: DOI: https://doi.org/10.1007/s00404-022-06438-y

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

adenomyosis

MeSH descriptors

Adenomyosis Adenomyosis Adenomyosis Adenomyosis Berberine Berberine Berberine Berberine Animals Animals Disease Models, Animal Disease Models, Animal Endometrium Endometrium Endometrium Female Female Humans Humans Hyperalgesia

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-10-13T06:10:10.580696+00:00
pubmed
last seen: 2026-10-08T21:34:14.286141+00:00
unpaywall
last seen: 2026-10-13T06:25:51.201866+00:00
License: public-domain-us · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine